Advertisement Greenphire opens new London Office - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Greenphire opens new London Office

Greenphire, a US-based payment technology provider for clinical trials industry, has opened its new London office, marking an expansion into the European market.

The expansion, which is a key part of the 2013 strategic plan, is expected to support the increasing demand for the company’s products and services.

The global payment technology platform for Patient as well as Investigator payments have seen increased adoption within the life sciences industry and the new office in London will play a critical role in continuing to build on the growth further, according to the company.

Greenphire founder and CEO Sam Whitaker said, "Establishing our presence in Europe allows us to support our Enterprise clients in those areas where they conduct research and development, facilitates stronger support of the many clinical investigators conducting research on behalf of biopharmaceutical companies and provides a base from which we can grow our commercial presence in Europe."